Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae
- PMID: 27745736
- DOI: 10.1016/j.diagmicrobio.2016.09.002
Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae
Abstract
We evaluated activity of apramycin, a non-ototoxic/non-nephrotoxic aminocyclitol against 141 clinical Enterobacteriaceae isolates, 51% of which were non-susceptible to carbapenems (CRE). Among CRE, 70.8% were apramycin susceptible, which compared favorably to aminoglycosides in current clinical use. Our data suggest that apramycin deserves further investigation as a repurposed, anti-CRE therapeutic.
Keywords: Activity spectrum; Aminoglycoside; Apramycin; Carbapenem-resistant Enterobacteriaceae; Multidrug-resistance; Repurposing.
Copyright © 2016 Elsevier Inc. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
